• Company
• Columvi can be prescribed at general hospitals in KOR
• by Eo, Yun-Ho Aug 12, 2024 05:55am

• Company
• Anticancer drug 'Alecensa' expected to win nod
• by Eo, Yun-Ho Aug 12, 2024 05:55am

• Company
• Prevenar maintains lead in pneumococcal vaccine mkt
• by Hwang, Byung-woo Aug 12, 2024 05:54am

• Company
• Rare disease drug Ilaris is reimbursed 9 yrs after approval
• by Hwang, Byung-woo Aug 11, 2024 04:46pm

• Company
• Yuhan acquires new drugs from biotech venture firms
• by Chon, Seung-Hyun Aug 9, 2024 05:34am

• Company
• SK Biopharmaceuticals records profit for 3 quarters
• by Kim, Jin-Gu Aug 9, 2024 02:55am

• Company
• Celltrion achieved highest ever sales in Q2
• by Hwang, Byung-woo Aug 8, 2024 03:37pm

• Company
• Revisions to the guidelines for atopic dermatitis treatment
• by Hwang, Byung-woo Aug 8, 2024 09:25am

• Company
• RSV vaccine market for children is expected to be big
• by Hwang, Byung-woo Aug 8, 2024 09:24am

• Company
• Celltrion presents clinical results of Prolia biosimilar
• by Hwang, Byung-woo Aug 8, 2024 09:24am